Nivolumab for the treatment of hepatocellular carcinoma
Author:
Affiliation:
1. Medizinische Klinik 1, Universitätsklinikum Frankfurt, Goethe-Universität, Frankfurt/Main, Germany
Publisher
Informa UK Limited
Subject
Pharmacology (medical),Oncology
Link
https://www.tandfonline.com/doi/pdf/10.1080/14737140.2018.1535315
Reference34 articles.
1. Immune Checkpoint Blockade: A Common Denominator Approach to Cancer Therapy
2. CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation.
3. Enhancement of Antitumor Immunity by CTLA-4 Blockade
4. Induced expression of PD-1, a novel member of the immunoglobulin gene superfamily, upon programmed cell death.
5. The human PD-1 gene: complete cDNA, genomic organization, and developmentally regulated expression in B cell progenitors
Cited by 97 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Prognostic biomarkers associated with immune checkpoint inhibitors in hepatocellular carcinoma;Immunology;2024-01-12
2. Knowledge mapping of immunotherapy in cervical carcinoma: a bibliometric analysis (2000-2023);Frontiers in Immunology;2024-01-09
3. Rising Star in Immunotherapy: Development and Therapeutic Potential of Small-Molecule Inhibitors Targeting Casitas B Cell Lymphoma-b (Cbl-b);Journal of Medicinal Chemistry;2024-01-05
4. Tanshinone IIA normalized hepatocellular carcinoma vessels and enhanced PD-1 inhibitor efficacy by inhibiting ELTD1;Phytomedicine;2024-01
5. The role of immune checkpoints in antitumor response: a potential antitumor immunotherapy;Frontiers in Immunology;2023-12-15
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"全球学者库"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前全球学者库共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2023 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3